Growth Metrics

Gilead Sciences (GILD) Minority Interest (2016 - 2026)

Gilead Sciences filings provide 17 years of Minority Interest readings, the most recent being -$84.0 million for Q4 2025.

  • On a quarterly basis, Minority Interest changed 0.0% to -$84.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$84.0 million, a 0.0% change, with the full-year FY2025 number at -$84.0 million, changed 0.0% from a year prior.
  • Minority Interest hit -$84.0 million in Q4 2025 for Gilead Sciences, roughly flat from -$84.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $12.0 million in Q1 2021 to a low of -$84.0 million in Q4 2023.
  • Median Minority Interest over the past 5 years was -$68.0 million (2023), compared with a mean of -$51.2 million.
  • Biggest five-year swings in Minority Interest: plummeted 2500.0% in 2022 and later changed 0.0% in 2024.
  • Gilead Sciences' Minority Interest stood at -$5.0 million in 2021, then plummeted by 520.0% to -$31.0 million in 2022, then crashed by 170.97% to -$84.0 million in 2023, then changed by 0.0% to -$84.0 million in 2024, then changed by 0.0% to -$84.0 million in 2025.
  • The last three reported values for Minority Interest were -$84.0 million (Q4 2025), -$84.0 million (Q3 2025), and -$84.0 million (Q2 2025) per Business Quant data.